Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
MatsukiyoCocokara (3088 JP)
Watchlist
112
Analysis
Consumer Staples
•
Japan
MatsukiyoCocokara & Co. operates drug store chains. The Company retails medicines, cosmetics, health foods, beauty care products, and other products. MatsukiyoCocokara & also operates supermarkets and home centers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Welcia Holdings
•
23 Oct 2022 10:48
Welcia Challenges Cosmos in Kyushu
Kyushu has become a hotbed of retail competition, especially in discount and drugstores. Aeon is determined to undermine the local champions,...
Michael Causton
Follow
308 Views
Share
bullish
•
iShares MSCI ACWI ex US ETF
•
30 Sep 2022 16:25
MSCI ACWI Ex-US, EAFE Testing Downtrend Channel Supports -- Bounce Potential
Bounce potential given $ACWX $EFA testing downtrend channel supports, but it would likely be a short-term trading opportunity due to the fact that...
Vermilion Research
Follow
514 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Sep 2022 14:33
Japan Weekly | JR East, Matsukiyo, IHI
Stocks in Japan are benefiting from continued expectations for a loosening of inbound tourist restrictions. Meanwhile, the drop in IHI could be an...
Mark Chadwick
Follow
299 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Aug 2022 21:39
Japan Tourism | 3 Stocks to Buy for Open Borders
Japan has been slow to reopen its borders post COVID. Under pressure to stimulate the economy, Kishida has committed to lifting the cap on...
Mark Chadwick
Follow
347 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Jul 2022 09:16
Drugstores in Japan: Winners and Losers
Japan's drugstore sector continues to grow but only a few retailers will emerge as winners as competitors carve out greater market share.
Michael Causton
Follow
339 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.6
x